Toll Free: 1-888-928-9744

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 1437 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Chronic Obstructive Pulmonary Disease (COPD) 29 May 24, 2016: Salford Lung Study results show COPD patients treated with Relvar Ellipta achieve superior reduction in exacerbations compared with 'usual care' 29 May 18, 2016: GSK presents new data from Breo Ellipta SUMMIT study in patients with COPD at ATS Conference 30 May 18, 2016: GSK presents efficacy data for Anoro Ellipta in COPD patients who remained symptomatic on tiotropium 31 May 18, 2016: An Extrafine ICS/LABA Combination Decreases COPD Exacerbations More Than LABA/LAMA: a Comparative Analysis Versus Bronchodilator Monotherapy 32 May 16, 2016: Sunovion Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 ATS Conference 32 May 10, 2016: Verona Pharma announces positive results from add-on phase II trial with RPL554 33 May 04, 2016: Sunovion Presents New Health Outcomes Data Supporting Brovana (arformoterol tartrate) Inhalation Solution in People with Moderate-to-Severe COPD at the 2016 American Thoracic Society (ATS) International Conference 34 Apr 27, 2016: Sunovion Pharmaceuticals Announces Positive Results from Two Phase 3 Clinical Studies Evaluating SUN-101/eFlow (glycopyrrolate) in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease 35 Apr 04, 2016: Invion Announces Successful Meeting With FDA To Progress Development Of INV102 35 Mar 15, 2016: Verona Pharma reports positive results from RPL554 dose-finding study 36 Clinical Trial Profile Snapshots 38 Appendix 1434 Abbreviations 1434 Definitions 1434 Research Methodology 1435 Secondary Research 1435 About GlobalData 1436 Contact Us 1436 Disclaimer 1436 Source 1437
List of Tables
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials, G7 Countries (%), 2016* 14 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials, E7 Countries (%), 2016* 17 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28


List of Figures
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials, G7 Countries (%), 2016* 14 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials, E7 Countries (%), 2016* 17 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 1435

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify